Gordon Michael Adam 4
4 · PAVmed Inc. · Filed Apr 3, 2026
Research Summary
AI-generated summary of this filing
PAVmed (PAVM) General Counsel Gordon Michael Adam Receives Restricted Stock Award
What Happened
Gordon Michael Adam, General Counsel of PAVmed, was granted 110,000 restricted shares (transaction code A) on April 2, 2026. The grant price is $0.00, so there was no cash exchanged. This was an equity award (not an open-market purchase or sale).
Key Details
- Transaction date: 2026-04-02; Filing date: 2026-04-03 (timely filing).
- Amount: 110,000 restricted shares granted at $0.00 (total cash value on grant = $0).
- Shares owned after transaction: not disclosed in the provided filing.
- Footnote: The shares are restricted stock issued under the Issuer’s Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan, with a single vesting date of May 20, 2029 and subject to forfeiture if the service period is not completed (Footnote F1).
- Transaction code: A = Award/Grant.
Context
Restricted stock awards are a form of compensation/retention and typically cannot be sold or transferred until they vest; they are not a market bet by the insider. This grant does not represent a sale or an open-market purchase and did not generate cash for the insider at grant.
Insider Transaction Report
Form 4
PAVmed Inc.PAVM
Gordon Michael Adam
General Counsel
Transactions
- Award
Common stock
[F1]2026-04-02+110,000→ 115,000 total
Footnotes (1)
- [F1]Represents restricted stock granted to the reporting person under the Issuer's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed.
Signature
/s/ Michael A. Gordon|2026-04-02